Breast Cancer Imaging and Therapy
In Canada, survival from breast cancer has steadily increased since 1989, and breast cancer mortality has decreased by 48%. While 82% of women with breast cancer are diagnosed at stage 1 or 2, there are still 18% who present at a late stage and 25% who develop metastatic disease. Improved survival h...
保存先:
| フォーマット: | Online |
|---|---|
| 言語: | 英語 |
| 出版事項: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| 主題: | |
| オンライン･アクセス: | ONIX_20230714_9783036579306_86 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
| _version_ | 1869523944507179008 |
|---|---|
| collection | Directory of Open Access Books |
| description | In Canada, survival from breast cancer has steadily increased since 1989, and breast cancer mortality has decreased by 48%. While 82% of women with breast cancer are diagnosed at stage 1 or 2, there are still 18% who present at a late stage and 25% who develop metastatic disease. Improved survival has been achieved through early diagnosis of breast cancer with screening, allowing for more effective and targeted treatments. This reprint summarizes the latest evidence on the early detection of breast cancer and highlights areas where this may be improved. |
| format | Online |
| id | doab-20.500.12854ir-101387 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1013872024-03-31T13:10:42Z Breast Cancer Imaging and Therapy Seely, Jean contrast-enhanced spectral mammography breast cancer neoadjuvant chemotherapy complete response response evaluation criteria in solid tumors contrast-enhanced mammography magnetic resonance imaging image enhancement contrast media radiomics artificial intelligence breast cancer screening dense patient advocacy breast density breast density notification Canada mammography breast ultrasound breast cancer screening interval cancer mortality reduction breast MRI digital breast tomosynthesis molecular breast imaging overdetection Canadian National Breast Screening Study overdiagnosis overtreatment microsimulation mammographic screening randomization expertise guidelines evidenc epistemic trespassing evidence-based medicine risk factors screening mammography knowledge assessment barriers questionnaire examination DBT ultrasound benign biopsy stage shift registries prevention recommendations clinical practice breast screening high-risk breast screening dense breasts supplemental breast screening cardiovascular disease chemotherapy radiotherapy mortality adjuvant endocrine therapy adherence to treatment side effects tamoxifen aromatase inhibitors GnRH agonist questionnaire n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology In Canada, survival from breast cancer has steadily increased since 1989, and breast cancer mortality has decreased by 48%. While 82% of women with breast cancer are diagnosed at stage 1 or 2, there are still 18% who present at a late stage and 25% who develop metastatic disease. Improved survival has been achieved through early diagnosis of breast cancer with screening, allowing for more effective and targeted treatments. This reprint summarizes the latest evidence on the early detection of breast cancer and highlights areas where this may be improved. 2023-07-14T14:29:07Z 2023-07-14T14:29:07Z 2023 book ONIX_20230714_9783036579306_86 9783036579306 9783036579313 https://directory.doabooks.org/handle/20.500.12854/101387 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/7483 https://mdpi.com/books/pdfview/book/7483 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-7931-3 10.3390/books978-3-0365-7931-3 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036579306 9783036579313 228 Basel open access |
| spellingShingle | contrast-enhanced spectral mammography breast cancer neoadjuvant chemotherapy complete response response evaluation criteria in solid tumors contrast-enhanced mammography magnetic resonance imaging image enhancement contrast media radiomics artificial intelligence breast cancer screening dense patient advocacy breast density breast density notification Canada mammography breast ultrasound breast cancer screening interval cancer mortality reduction breast MRI digital breast tomosynthesis molecular breast imaging overdetection Canadian National Breast Screening Study overdiagnosis overtreatment microsimulation mammographic screening randomization expertise guidelines evidenc epistemic trespassing evidence-based medicine risk factors screening mammography knowledge assessment barriers questionnaire examination DBT ultrasound benign biopsy stage shift registries prevention recommendations clinical practice breast screening high-risk breast screening dense breasts supplemental breast screening cardiovascular disease chemotherapy radiotherapy mortality adjuvant endocrine therapy adherence to treatment side effects tamoxifen aromatase inhibitors GnRH agonist questionnaire n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Breast Cancer Imaging and Therapy |
| title | Breast Cancer Imaging and Therapy |
| title_full | Breast Cancer Imaging and Therapy |
| title_fullStr | Breast Cancer Imaging and Therapy |
| title_full_unstemmed | Breast Cancer Imaging and Therapy |
| title_short | Breast Cancer Imaging and Therapy |
| title_sort | breast cancer imaging and therapy |
| topic | contrast-enhanced spectral mammography breast cancer neoadjuvant chemotherapy complete response response evaluation criteria in solid tumors contrast-enhanced mammography magnetic resonance imaging image enhancement contrast media radiomics artificial intelligence breast cancer screening dense patient advocacy breast density breast density notification Canada mammography breast ultrasound breast cancer screening interval cancer mortality reduction breast MRI digital breast tomosynthesis molecular breast imaging overdetection Canadian National Breast Screening Study overdiagnosis overtreatment microsimulation mammographic screening randomization expertise guidelines evidenc epistemic trespassing evidence-based medicine risk factors screening mammography knowledge assessment barriers questionnaire examination DBT ultrasound benign biopsy stage shift registries prevention recommendations clinical practice breast screening high-risk breast screening dense breasts supplemental breast screening cardiovascular disease chemotherapy radiotherapy mortality adjuvant endocrine therapy adherence to treatment side effects tamoxifen aromatase inhibitors GnRH agonist questionnaire n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| topic_facet | contrast-enhanced spectral mammography breast cancer neoadjuvant chemotherapy complete response response evaluation criteria in solid tumors contrast-enhanced mammography magnetic resonance imaging image enhancement contrast media radiomics artificial intelligence breast cancer screening dense patient advocacy breast density breast density notification Canada mammography breast ultrasound breast cancer screening interval cancer mortality reduction breast MRI digital breast tomosynthesis molecular breast imaging overdetection Canadian National Breast Screening Study overdiagnosis overtreatment microsimulation mammographic screening randomization expertise guidelines evidenc epistemic trespassing evidence-based medicine risk factors screening mammography knowledge assessment barriers questionnaire examination DBT ultrasound benign biopsy stage shift registries prevention recommendations clinical practice breast screening high-risk breast screening dense breasts supplemental breast screening cardiovascular disease chemotherapy radiotherapy mortality adjuvant endocrine therapy adherence to treatment side effects tamoxifen aromatase inhibitors GnRH agonist questionnaire n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| url | ONIX_20230714_9783036579306_86 |